What is Simponi?
Simponi (also known by its generic name golimumab) is a TNF-alpha inhibitor biologic medication that was approved by the FDA in April 2009 to treat adults with active psoriatic arthritis. It is also approved for rheumatoid arthritis and ankylosing spondylitis.
Patients take Simponi by giving themselves an injection under the skin once a month. Simponi is designed to be taken continuously to maintain improvement.
To learn more, please visit the Simponi website.
Learn more about types of oral systemic, biologic, and biosimilar treatments including their risks and side effects.
The Patient Navigation Center is here to provide personalized information about your psoriasis and psoriatic arthritis treatment.
Last updated on 3/24/25 by the National Psoriasis Foundation.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.
